|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/53 | |
| A61K 45/06 | |||
| C12Q 1/68 |
| (11) | Patento numeris | 1910825 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06710533.8 |
| Europos patento paraiškos padavimo data | 2006-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-04-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-08-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2006/000533 |
| Data | 2006-03-10 |
| (87) | Numeris | WO 2006/095259 |
| Data | 2006-09-14 |
| (30) | Numeris | Data | Šalis |
| 661192 P | 2005-03-11 | US |
| (72) |
FIRAT, Hueseyin, FR
BOISCLAIR, Julie, CH
GRENET, Olivier, FR
PERENTES, Elias, CH
SCHUMACHER, Martin, M., CH
|
| (73) |
Firalis SAS,
35 rue de Fort, 68330 Huningue,
FR
|
| (54) | BIOMARKERS FOR CARDIOVASCULAR SIDE-EFFECTS INDUCED BY COX-2 INHIBITORY COMPOUNDS |
| BIOMARKERS FOR CARDIOVASCULAR SIDE-EFFECTS INDUCED BY COX-2 INHIBITORY COMPOUNDS |